Global and United States Meloxicam Drug Market 2020 by Manufacturers, Type and Application, Forecast to 2025
Market Overview
The global Meloxicam Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Meloxicam Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Meloxicam Drug market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Breakdown by Type, Meloxicam Drug market has been segmented into Tablet, Capsule, etc.
Breakdown by Application, Meloxicam Drug has been segmented into Osteoarthritis in adults (OA), Rheumatoid Arthritis in adults (RA), Pediatric patients, etc.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Meloxicam Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Meloxicam Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meloxicam Drug market.
For United States, this report analyses the United States market by players, Type and Application, for the period 2015-2025.
Competitive Landscape and Meloxicam Drug Market Share Analysis
Meloxicam Drug competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, Meloxicam Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meloxicam Drug sales, revenue and market share for each player covered in this report.
The major players covered in Meloxicam Drug are: Boehringer-Ingelheim, Unichem Pharmaceuticals, Apotex, TerSera Therapeutics, Zydus Pharmaceuticals, Iroko Pharmaceuticals, Cipla, Breckenridge Pharmaceutical, Yung Shin Pharmaceutical, Strides Pharma, TARO, Dr. Reddy's Laboratories, Lupin Pharmaceuticals, PuraCap Pharmaceutical, Glenmark Pharmaceuticals, Aurobindo Pharma, Teva, etc. Among other players domestic and global, Meloxicam Drug market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The key market players for global Meloxicam Drug market are listed below:
Boehringer-Ingelheim
Unichem Pharmaceuticals
Apotex
TerSera Therapeutics
Zydus Pharmaceuticals
Iroko Pharmaceuticals
Cipla
Breckenridge Pharmaceutical
Yung Shin Pharmaceutical
Strides Pharma
TARO
Dr. Reddy's Laboratories
Lupin Pharmaceuticals
PuraCap Pharmaceutical
Glenmark Pharmaceuticals
Aurobindo Pharma
Teva
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)
Market segment by Type, covers:
Tablet
Capsule
Market segment by Application, can be divided into
Osteoarthritis in adults (OA)
Rheumatoid Arthritis in adults (RA)
Pediatric patients
Table of Contents
1 Market Overview
1.1 Meloxicam Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meloxicam Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Tablet
1.2.3 Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Meloxicam Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Osteoarthritis in adults (OA)
1.3.3 Rheumatoid Arthritis in adults (RA)
1.3.4 Pediatric patients
1.4 Global Meloxicam Drug Market Size and Forecast (2015-2025)
1.4.1 Global Meloxicam Drug Revenue and Forecast (2015-2025)
1.4.2 Global Meloxicam Drug Sales and Forecast (2015-2025)
1.5 Global Meloxicam Drug Market Size Overview by Geography (2015-2020)
2 Manufacturers Profiles
2.1 Boehringer-Ingelheim
2.1.1 Boehringer-Ingelheim Details
2.1.2 Boehringer-Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer-Ingelheim SWOT Analysis
2.1.4 Boehringer-Ingelheim Product and Services
2.1.5 Boehringer-Ingelheim Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Unichem Pharmaceuticals
2.2.1 Unichem Pharmaceuticals Details
2.2.2 Unichem Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Unichem Pharmaceuticals SWOT Analysis
2.2.4 Unichem Pharmaceuticals Product and Services
2.2.5 Unichem Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Apotex
2.3.1 Apotex Details
2.3.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Apotex SWOT Analysis
2.3.4 Apotex Product and Services
2.3.5 Apotex Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 TerSera Therapeutics
2.4.1 TerSera Therapeutics Details
2.4.2 TerSera Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 TerSera Therapeutics SWOT Analysis
2.4.4 TerSera Therapeutics Product and Services
2.4.5 TerSera Therapeutics Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Zydus Pharmaceuticals
2.5.1 Zydus Pharmaceuticals Details
2.5.2 Zydus Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Zydus Pharmaceuticals SWOT Analysis
2.5.4 Zydus Pharmaceuticals Product and Services
2.5.5 Zydus Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Iroko Pharmaceuticals
2.6.1 Iroko Pharmaceuticals Details
2.6.2 Iroko Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Iroko Pharmaceuticals SWOT Analysis
2.6.4 Iroko Pharmaceuticals Product and Services
2.6.5 Iroko Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cipla
2.7.1 Cipla Details
2.7.2 Cipla Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Cipla SWOT Analysis
2.7.4 Cipla Product and Services
2.7.5 Cipla Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Breckenridge Pharmaceutical
2.8.1 Breckenridge Pharmaceutical Details
2.8.2 Breckenridge Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Breckenridge Pharmaceutical SWOT Analysis
2.8.4 Breckenridge Pharmaceutical Product and Services
2.8.5 Breckenridge Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Yung Shin Pharmaceutical
2.9.1 Yung Shin Pharmaceutical Details
2.9.2 Yung Shin Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Yung Shin Pharmaceutical SWOT Analysis
2.9.4 Yung Shin Pharmaceutical Product and Services
2.9.5 Yung Shin Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Strides Pharma
2.10.1 Strides Pharma Details
2.10.2 Strides Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Strides Pharma SWOT Analysis
2.10.4 Strides Pharma Product and Services
2.10.5 Strides Pharma Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 TARO
2.11.1 TARO Details
2.11.2 TARO Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 TARO SWOT Analysis
2.11.4 TARO Product and Services
2.11.5 TARO Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 Dr. Reddy's Laboratories
2.12.1 Dr. Reddy's Laboratories Details
2.12.2 Dr. Reddy's Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Dr. Reddy's Laboratories SWOT Analysis
2.12.4 Dr. Reddy's Laboratories Product and Services
2.12.5 Dr. Reddy's Laboratories Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Lupin Pharmaceuticals
2.13.1 Lupin Pharmaceuticals Details
2.13.2 Lupin Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Lupin Pharmaceuticals SWOT Analysis
2.13.4 Lupin Pharmaceuticals Product and Services
2.13.5 Lupin Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 PuraCap Pharmaceutical
2.14.1 PuraCap Pharmaceutical Details
2.14.2 PuraCap Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 PuraCap Pharmaceutical SWOT Analysis
2.14.4 PuraCap Pharmaceutical Product and Services
2.14.5 PuraCap Pharmaceutical Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 Glenmark Pharmaceuticals
2.15.1 Glenmark Pharmaceuticals Details
2.15.2 Glenmark Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Glenmark Pharmaceuticals SWOT Analysis
2.15.4 Glenmark Pharmaceuticals Product and Services
2.15.5 Glenmark Pharmaceuticals Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Aurobindo Pharma
2.16.1 Aurobindo Pharma Details
2.16.2 Aurobindo Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Aurobindo Pharma SWOT Analysis
2.16.4 Aurobindo Pharma Product and Services
2.16.5 Aurobindo Pharma Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Teva SWOT Analysis
2.17.4 Teva Product and Services
2.17.5 Teva Meloxicam Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Global Meloxicam Drug Market, Company Landscape
3.1 Company Market Share Analysis: Global
3.1.1 Global Meloxicam Drug Sales and Market Share by Manufacturer (2018-2019)
3.1.2 Global Meloxicam Drug Revenue and Market Share by Manufacturer (2018-2019)
3.2 Company Market Share Analysis: United States
3.2.1 Key Players Meloxicam Drug Sales in United States (2018-2019)
3.2.2 United States Meloxicam Drug Revenue Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Meloxicam Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Meloxicam Drug Manufacturer Market Share in 2019
4 Market Size by Geography
4.1 Global Meloxicam Drug Market Size by Geography (2015-2020)
4.1.1 Global Meloxicam Drug Sales by Geography (2015-2020)
4.1.2 Global Meloxicam Drug Revenue by Regions (2015-2020)
4.2 Global Meloxicam Drug Market Size and Forecast by Regions (2020-2025)
4.2.1 Global Meloxicam Drug Sales and Forecast by Regions (2020-2025)
4.2.2 Global Meloxicam Drug Revenue and Forecast by Regions (2020-2025)
4.3 North America Meloxicam Drug Market Size and Forecast (2015-2025)
4.4 Europe Meloxicam Drug Market Size and Forecast (2015-2025)
4.5 Asia-Pacific Meloxicam Drug Market Size and Forecast (2015-2025)
4.6 South America Meloxicam Drug Market Size and Forecast (2015-2025)
4.7 Middle East and Africa Meloxicam Drug Market Size and Forecast (2015-2025)
5 North America by Country
5.1 North America Meloxicam Drug Market Size by Country (2015-2020)
5.1.1 North America Meloxicam Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Meloxicam Drug Revenue and Market Share by Country (2015-2020)
5.2 North America Meloxicam Drug Market Size and Forecast by Country (2020-2025)
5.2.1 North America Meloxicam Drug Sales and Forecast by Country (2020-2025)
5.2.2 North America Meloxicam Drug Revenue and Forecast by Country (2020-2025)
5.3 United States Meloxicam Drug Market Size and Forecast (2015-2025)
5.4 Canada Meloxicam Drug Market Size and Forecast (2015-2025)
5.5 Mexico Meloxicam Drug Market Size and Forecast (2015-2025)
6 Europe by Country
6.1 Europe Meloxicam Drug Market Size by Country (2015-2020)
6.1.1 Europe Meloxicam Drug Sales by Country (2015-2020)
6.1.2 Europe Meloxicam Drug Revenue by Country (2015-2020)
6.2 Europe Meloxicam Drug Market Size and Forecast by Country (2020-2025)
6.2.1 Europe Meloxicam Drug Sales and Forecast by Country (2020-2025)
6.2.2 Europe Meloxicam Drug Revenue and Forecast by Country (2020-2025)
6.3 Germany Meloxicam Drug Market Size and Forecast (2015-2025)
6.4 United Kingdom Meloxicam Drug Market Size and Forecast (2015-2025)
6.5 France Meloxicam Drug Market Size and Forecast (2015-2025)
6.6 Russia Meloxicam Drug Market Size and Forecast (2015-2025)
6.7 Italy Meloxicam Drug Market Size and Forecast (2015-2025)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Meloxicam Drug Market Size by Region (2015-2020)
7.1.1 Asia-Pacific Meloxicam Drug Sales by Region (2015-2020)
7.1.2 Asia-Pacific Meloxicam Drug Revenue by Region (2015-2020)
7.2 Asia-Pacific Meloxicam Drug Market Size and Forecast by Region (2020-2025)
7.2.1 Asia-Pacific Meloxicam Drug Sales and Forecast by Region (2020-2025)
7.2.2 Asia-Pacific Meloxicam Drug Revenue and Forecast by Region (2020-2025)
7.3 China Meloxicam Drug Market Size and Forecast (2015-2025)
7.4 Japan Meloxicam Drug Market Size and Forecast (2015-2025)
7.5 Korea Meloxicam Drug Market Size and Forecast (2015-2025)
7.6 India Meloxicam Drug Market Size and Forecast (2015-2025)
7.7 Southeast Asia Meloxicam Drug Market Size and Forecast (2015-2025)
7.8 Australia Meloxicam Drug Market Size and Forecast (2015-2025)
8 South America by Country
8.1 South America Meloxicam Drug Market Size by Country (2015-2020)
8.1.1 South America Meloxicam Drug Sales by Country (2015-2020)
8.1.2 South America Meloxicam Drug Revenue by Country (2015-2020)
8.2 South America Meloxicam Drug Market Size and Forecast by Country (2020-2025)
8.2.1 South America Meloxicam Drug Sales and Forecast by Country (2020-2025)
8.2.2 South America Meloxicam Drug Revenue and Forecast by Country (2020-2025)
8.3 Brazil Meloxicam Drug Market Size and Forecast (2015-2025)
8.4 Argentina Meloxicam Drug Market Size and Forecast (2015-2025)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Meloxicam Drug Market Size by Country (2015-2020)
9.1.1 Middle East & Africa Meloxicam Drug Sales by Country (2015-2020)
9.1.2 Middle East & Africa Meloxicam Drug Revenue by Country (2015-2020)
9.2 Middle East & Africa Meloxicam Drug Market Size and Forecast by Country (2020-2025)
9.2.1 Middle East & Africa Meloxicam Drug Sales and Forecast by Country (2020-2025)
9.2.2 Middle East & Africa Meloxicam Drug Revenue and Forecast by Country (2020-2025)
9.3 Saudi Arabia Meloxicam Drug Market Size and Forecast (2015-2025)
9.4 Turkey Meloxicam Drug Market Size and Forecast (2015-2025)
9.5 Egypt Meloxicam Drug Market Size and Forecast (2015-2025)
9.6 South Africa Meloxicam Drug Market Size and Forecast (2015-2025)
10 Market Segment by Type
10.1 Global Meloxicam Drug Market Size by Type (2015-2020)
10.1.1 Global Meloxicam Drug Sales by Type (2015-2020)
10.1.2 Global Meloxicam Drug Revenue by Type (2015-2020)
10.1.3 Global Meloxicam Drug Price by Type (2015-2020)
10.2 Global Meloxicam Drug Market Size and Forecast by Type (2020-2025)
10.2.1 Global Meloxicam Drug Sales and Forecast by Type (2020-2025)
10.2.2 Global Meloxicam Drug Revenue and Forecast by Type (2020-2025)
10.2.3 Global Meloxicam Drug Price and Forecast by Type (2020-2025)
10.3 United States Meloxicam Drug Market Size and Forecast by Type (2015-2025)
10.3.1 United States Meloxicam Drug Market Size by Type (2015-2020)
10.3.2 United States Meloxicam Drug Market Size and Forecast by Type (2020-2025)
11 Market Segment by Application
11.1 Global Meloxicam Drug Market Size by Application (2015-2020)
11.1.1 Global Meloxicam Drug Sales by Application (2015-2020)
11.1.2 Global Meloxicam Drug Revenue by Application (2015-2020)
11.1.3 Global Meloxicam Drug Price by Application (2015-2020)
11.2 Global Meloxicam Drug Market Size and Forecast by Application (2020-2025)
11.2.1 Global Meloxicam Drug Sales and Forecast by Application (2020-2025)
11.2.2 Global Meloxicam Drug Revenue and Forecast by Application (2020-2025)
11.2.3 Global Meloxicam Drug Price and Forecast by Application (2020-2025)
11.3 United States Meloxicam Drug Market Size and Forecast by Application (2015-2025)
11.3.1 United States Meloxicam Drug Market Size by Application (2015-2020)
11.3.2 United States Meloxicam Drug Market Size and Forecast by Application (2020-2025)
12 Sales Channel, Distributors, Costumers, and Market Dynamics
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Distributors, Traders and Dealers
12.4.1 Market Opportunities
12.4.2 Market Risk
12.4.3 Market Driving Force
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Tables and Figures
List of Tables
Table 1. Global Meloxicam Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Meloxicam Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Meloxicam Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Meloxicam Drug Market Size Overview by Geography (2015-2020) (USD Million)
Table 5. Boehringer-Ingelheim Basic Information, Manufacturing Base and Competitors
Table 6. Boehringer-Ingelheim Meloxicam Drug Major Business
Table 7. Boehringer-Ingelheim Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 8. Boehringer-Ingelheim SWOT Analysis
Table 9. Boehringer-Ingelheim Meloxicam Drug Product and Services
Table 10. Boehringer-Ingelheim Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 11. Unichem Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 12. Unichem Pharmaceuticals Meloxicam Drug Major Business
Table 13. Unichem Pharmaceuticals Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 14. Unichem Pharmaceuticals SWOT Analysis
Table 15. Unichem Pharmaceuticals Meloxicam Drug Product and Services
Table 16. Unichem Pharmaceuticals Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 17. Apotex Basic Information, Manufacturing Base and Competitors
Table 18. Apotex Meloxicam Drug Major Business
Table 19. Apotex Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 20. Apotex SWOT Analysis
Table 21. Apotex Meloxicam Drug Product and Services
Table 22. Apotex Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 23. TerSera Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. TerSera Therapeutics Meloxicam Drug Major Business
Table 25. TerSera Therapeutics Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 26. TerSera Therapeutics SWOT Analysis
Table 27. TerSera Therapeutics Meloxicam Drug Product and Services
Table 28. TerSera Therapeutics Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 29. Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 30. Zydus Pharmaceuticals Meloxicam Drug Major Business
Table 31. Zydus Pharmaceuticals Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 32. Zydus Pharmaceuticals SWOT Analysis
Table 33. Zydus Pharmaceuticals Meloxicam Drug Product and Services
Table 34. Zydus Pharmaceuticals Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 35. Iroko Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Iroko Pharmaceuticals Meloxicam Drug Major Business
Table 37. Iroko Pharmaceuticals Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 38. Iroko Pharmaceuticals SWOT Analysis
Table 39. Iroko Pharmaceuticals Meloxicam Drug Product and Services
Table 40. Iroko Pharmaceuticals Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 41. Cipla Basic Information, Manufacturing Base and Competitors
Table 42. Cipla Meloxicam Drug Major Business
Table 43. Cipla Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 44. Cipla SWOT Analysis
Table 45. Cipla Meloxicam Drug Product and Services
Table 46. Cipla Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 47. Breckenridge Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 48. Breckenridge Pharmaceutical Meloxicam Drug Major Business
Table 49. Breckenridge Pharmaceutical Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 50. Breckenridge Pharmaceutical SWOT Analysis
Table 51. Breckenridge Pharmaceutical Meloxicam Drug Product and Services
Table 52. Breckenridge Pharmaceutical Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 53. Yung Shin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 54. Yung Shin Pharmaceutical Meloxicam Drug Major Business
Table 55. Yung Shin Pharmaceutical Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 56. Yung Shin Pharmaceutical SWOT Analysis
Table 57. Yung Shin Pharmaceutical Meloxicam Drug Product and Services
Table 58. Yung Shin Pharmaceutical Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 59. Strides Pharma Basic Information, Manufacturing Base and Competitors
Table 60. Strides Pharma Meloxicam Drug Major Business
Table 61. Strides Pharma Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 62. Strides Pharma SWOT Analysis
Table 63. Strides Pharma Meloxicam Drug Product and Services
Table 64. Strides Pharma Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 65. TARO Basic Information, Manufacturing Base and Competitors
Table 66. TARO Meloxicam Drug Major Business
Table 67. TARO Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 68. TARO SWOT Analysis
Table 69. TARO Meloxicam Drug Product and Services
Table 70. TARO Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 71. Dr. Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 72. Dr. Reddy's Laboratories Meloxicam Drug Major Business
Table 73. Dr. Reddy's Laboratories Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 74. Dr. Reddy's Laboratories SWOT Analysis
Table 75. Dr. Reddy's Laboratories Meloxicam Drug Product and Services
Table 76. Dr. Reddy's Laboratories Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 77. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 78. Lupin Pharmaceuticals Meloxicam Drug Major Business
Table 79. Lupin Pharmaceuticals Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 80. Lupin Pharmaceuticals SWOT Analysis
Table 81. Lupin Pharmaceuticals Meloxicam Drug Product and Services
Table 82. Lupin Pharmaceuticals Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 83. PuraCap Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 84. PuraCap Pharmaceutical Meloxicam Drug Major Business
Table 85. PuraCap Pharmaceutical Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 86. PuraCap Pharmaceutical SWOT Analysis
Table 87. PuraCap Pharmaceutical Meloxicam Drug Product and Services
Table 88. PuraCap Pharmaceutical Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 89. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 90. Glenmark Pharmaceuticals Meloxicam Drug Major Business
Table 91. Glenmark Pharmaceuticals Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 92. Glenmark Pharmaceuticals SWOT Analysis
Table 93. Glenmark Pharmaceuticals Meloxicam Drug Product and Services
Table 94. Glenmark Pharmaceuticals Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 95. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors
Table 96. Aurobindo Pharma Meloxicam Drug Major Business
Table 97. Aurobindo Pharma Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 98. Aurobindo Pharma SWOT Analysis
Table 99. Aurobindo Pharma Meloxicam Drug Product and Services
Table 100. Aurobindo Pharma Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 101. Teva Basic Information, Manufacturing Base and Competitors
Table 102. Teva Meloxicam Drug Major Business
Table 103. Teva Meloxicam Drug Total Revenue (USD Million) (2018-2019)
Table 104. Teva SWOT Analysis
Table 105. Teva Meloxicam Drug Product and Services
Table 106. Teva Meloxicam Drug Sales (K MT), Price (USD/MT), Revenue, Gross Margin and Market Share (2018-2019)
Table 107. Global Meloxicam Drug Sales by Manufacturer (2018-2019) (K MT)
Table 108. Global Meloxicam Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 109. Key Players Meloxicam Drug Sales in United States (2018-2019) (K MT)
Table 110. Key Players Meloxicam Drug Sales Market Share in United States (2018-2019)
Table 111. Key Players Revenue of Meloxicam Drug in United States (2018-2019) (USD Million)
Table 112. Global Meloxicam Drug Sales by Regions (2015-2020) (K MT)
Table 113. Global Meloxicam Drug Sales Market Share by Regions (2015-2020)
Table 114. Global Meloxicam Drug Revenue by Regions (2015-2020) (USD Million)
Table 115. Global Meloxicam Drug Sales and Forecast by Regions (2020-2025) (K MT)
Table 116. Global Meloxicam Drug Sales Market Share by Regions (2020-2025)
Table 117. Global Meloxicam Drug Revenue and Forecast by Regions (2020-2025) (USD Million)
Table 118. Global Meloxicam Drug Revenue Market Share by Regions (2020-2025) (USD Million)
Table 119. North America Meloxicam Drug Sales by Countries (2015-2020) (K MT)
Table 120. North America Meloxicam Drug Sales Market Share by Countries (2015-2020)
Table 121. North America Meloxicam Drug Revenue by Countries (2015-2020) (USD Million)
Table 122. North America Meloxicam Drug Revenue Market Share by Countries (2015-2020)
Table 123. North America Meloxicam Drug Sales by Country (2020-2025) (K MT)
Table 124. North America Meloxicam Drug Sales Market Share by Country (2020-2025)
Table 125. North America Meloxicam Drug Revenue by Country (2020-2025) (USD Million)
Table 126. North America Meloxicam Drug Revenue Market Share by Country (2020-2025)
Table 127. Europe Meloxicam Drug Sales by Countries (2015-2020) (K MT)
Table 128. Europe Meloxicam Drug Sales Market Share by Countries (2015-2020)
Table 129. Europe Meloxicam Drug Revenue by Countries (2015-2020) (USD Million)
Table 130. Europe Meloxicam Drug Revenue Market Share by Countries (2015-2020)
Table 131. Europe Meloxicam Drug Sales by Country (2020-2025) (K MT)
Table 132. Europe Meloxicam Drug Sales Market Share by Country (2020-2025)
Table 133. Europe Meloxicam Drug Revenue by Country (2020-2025) (USD Million)
Table 134. Europe Meloxicam Drug Revenue Market Share by Country (2020-2025)
Table 135. Asia-Pacific Meloxicam Drug Sales by Countries (2015-2020) (K MT)
Table 136. Asia-Pacific Meloxicam Drug Sales Market Share by Countries (2015-2020)
Table 137. Asia-Pacific Meloxicam Drug Revenue by Countries (2015-2020) (USD Million)
Table 138. Asia-Pacific Meloxicam Drug Revenue Market Share by Countries (2015-2020)
Table 139. Asia-Pacific Meloxicam Drug Sales by Country (2020-2025) (K MT)
Table 140. Asia-Pacific Meloxicam Drug Sales Market Share by Country (2020-2025)
Table 141. Asia-Pacific Meloxicam Drug Revenue by Country (2020-2025) (USD Million)
Table 142. Asia-Pacific Meloxicam Drug Revenue Market Share by Country (2020-2025)
Table 143. South America Meloxicam Drug Sales by Countries (2015-2020) (K MT)
Table 144. South America Meloxicam Drug Sales Market Share by Countries (2015-2020)
Table 145. South America Meloxicam Drug Revenue by Countries (2015-2020) (USD Million)
Table 146. South America Meloxicam Drug Revenue Market Share by Countries (2015-2020)
Table 147. South America Meloxicam Drug Sales by Country (2020-2025) (K MT)
Table 148. South America Meloxicam Drug Sales Market Share by Country (2020-2025)
Table 149. South America Meloxicam Drug Revenue by Country (2020-2025) (USD Million)
Table 150. South America Meloxicam Drug Revenue Market Share by Country (2020-2025)
Table 151. Middle East & Africa Meloxicam Drug Sales by Countries (2015-2020) (K MT)
Table 152. Middle East & Africa Meloxicam Drug Sales Market Share by Countries (2015-2020)
Table 153. Middle East & Africa Meloxicam Drug Revenue by Countries (2015-2020) (USD Million)
Table 154. Middle East & Africa Meloxicam Drug Revenue Market Share by Countries (2015-2020)
Table 155. Middle East & Africa Meloxicam Drug Sales by Country (2020-2025) (K MT)
Table 156. Middle East & Africa Meloxicam Drug Sales Market Share by Country (2020-2025)
Table 157. Middle East & Africa Meloxicam Drug Revenue by Country (2020-2025) (USD Million)
Table 158. Middle East & Africa Meloxicam Drug Revenue Market Share by Country (2020-2025)
Table 159. United States Meloxicam Drug Sales by Type (2015-2020) (K MT)
Table 160. United States Meloxicam Drug Sales Market Share by Type (2015-2020)
Table 161. United States Meloxicam Drug Revenue by Type (2015-2020) (USD Million)
Table 162. United States Meloxicam Drug Revenue Market Share by Type (2015-2020)
Table 163. United States Meloxicam Drug Sales by Type (2020-2025) (K MT)
Table 164. United States Meloxicam Drug Sales Market Share by Type (2020-2025)
Table 165. United States Meloxicam Drug Revenue by Type (2020-2025) (USD Million)
Table 166. United States Meloxicam Drug Revenue Market Share by Type (2020-2025)
Table 167. Global Meloxicam Drug Sales by Application (2015-2020) (K MT)
Table 168. Global Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 169. Global Meloxicam Drug Revenue by Application (2015-2020) (USD Million)
Table 170. Global Meloxicam Drug Revenue Market Share by Application (2015-2020)
Table 171. Global Meloxicam Drug Price by Application (2015-2020) (USD/MT)
Table 172. Global Meloxicam Drug Sales by Application (2020-2025) (K MT)
Table 173. Global Meloxicam Drug Sales Market Share by Application (2020-2025)
Table 174. Global Meloxicam Drug Revenue by Application (2020-2025) (USD Million)
Table 175. Global Meloxicam Drug Revenue Market Share by Application (2020-2025)
Table 176. Global Meloxicam Drug Price by Application (2020-2025) (USD/MT)
Table 177. United States Meloxicam Drug Sales by Application (2015-2020) (K MT)
Table 178. United States Meloxicam Drug Sales Market Share by Application (2015-2020)
Table 179. United States Meloxicam Drug Revenue by Application (2015-2020) (USD Million)
Table 180. United States Meloxicam Drug Revenue Market Share by Application (2015-2020)
Table 181. United States Meloxicam Drug Sales by Application (2020-2025) (K MT)
Table 182. United States Meloxicam Drug Sales Market Share by Application (2020-2025)
Table 183. United States Meloxicam Drug Revenue by Application (2020-2025) (USD Million)
Table 184. United States Meloxicam Drug Revenue Market Share by Application (2020-2025)
Table 185. Direct Channel Pros & Cons
Table 186. Indirect Channel Pros & Cons
Table 187. Distributors/Traders/ Dealers List
Table 188. Customers of Meloxicam Drug
Table 189. Market Opportunities in Next Few Years
Table 190. Market Risks Analysis
Table 191. Market Drivers
List of Figures
Figure 1. Meloxicam Drug Picture
Figure 2. Global Meloxicam Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 3. Tablet Picture
Figure 4. Capsule Picture
Figure 5. Meloxicam Drug Sales Market Share by Application in 2019
Figure 6. Osteoarthritis in adults (OA) Picture
Figure 7. Rheumatoid Arthritis in adults (RA) Picture
Figure 8. Pediatric patients Picture
Figure 9. Global Meloxicam Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 10. Global Meloxicam Drug Sales Growth Rate (2015-2025) (K MT)
Figure 11. Global Meloxicam Drug Sales Market Share by Manufacturer in 2019
Figure 12. Global Meloxicam Drug Revenue Market Share by Manufacturer in 2019
Figure 13. Key Players Meloxicam Drug Revenue Market Share in United States in 2019
Figure 14. Global Top 5 Meloxicam Drug Manufacturer Market Share in 2019
Figure 15. Top 3 Meloxicam Drug Players Market Share in United States in 2019
Figure 16. Global Meloxicam Drug Revenue Market Share by Regions in 2019
Figure 17. North America Meloxicam Drug Sales YoY Growth (2015-2025) (K MT)
Figure 18. North America Meloxicam Drug Revenue YoY Growth (2015-2025) (USD Million)
Figure 19. Europe Meloxicam Drug Sales YoY Growth (2015-2020) (K MT)
Figure 20. Europe Meloxicam Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 21. Asia-Pacific Meloxicam Drug Sales YoY Growth (2015-2020) (K MT)
Figure 22. Asia-Pacific Meloxicam Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 23. South America Meloxicam Drug Sales YoY Growth (2015-2020) (K MT)
Figure 24. South America Meloxicam Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 25. Middle East & Africa Meloxicam Drug Sales YoY Growth (2015-2020) (K MT)
Figure 26. Middle East & Africa Meloxicam Drug Revenue YoY Growth (2015-2020) (USD Million)
Figure 27. North America Meloxicam Drug Sales Market Share by Country in 2019
Figure 28. North America Meloxicam Drug Revenue Market Share by Country in 2019
Figure 29. United States Meloxicam Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 30. Canada Meloxicam Drug Market Size and Growth Rate (2015-2025) (USD Million)
Figure 31. Mexico Meloxicam Drug Market Size and Growth Rate (2015-2020) (USD Million)
Figure 32. Europe Meloxicam Drug Revenue Market Share by Country in 2019
Figure 33. Germany Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 34. United Kingdom Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 35. France Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 36. Russia Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 37. Italy Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 38. Asia-Pacific Meloxicam Drug Sales Market Share by Region 2018
Figure 39. Asia-Pacific Meloxicam Drug Revenue Market Share by Region 2018
Figure 40. China Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 41. Japan Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 42. Korea Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 43. India Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 44. Southeast Asia Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 45. Australia Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 46. South America Meloxicam Drug Sales Market Share by Country in 2019
Figure 47. South America Meloxicam Drug Revenue Market Share by Country in 2019
Figure 48. Brazil Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 49. Argentina Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 50. Saudi Arabia Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 51. Turkey Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 52. Egypt Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 53. South Africa Meloxicam Drug Market Size Growth Rate (2015-2025) (USD Million)
Figure 54. Global Revenue Market Share of Meloxicam Drug by Type in 2019
Figure 55. Global Revenue Market Share of Meloxicam Drug by Application in 2019
Figure 56. Sales Channel: Direct Channel vs Indirect Channel
Companies Mentioned
Boehringer-Ingelheim
Unichem Pharmaceuticals
Apotex
TerSera Therapeutics
Zydus Pharmaceuticals
Iroko Pharmaceuticals
Cipla
Breckenridge Pharmaceutical
Yung Shin Pharmaceutical
Strides Pharma
TARO
Dr. Reddy's Laboratories
Lupin Pharmaceuticals
PuraCap Pharmaceutical
Glenmark Pharmaceuticals
Aurobindo Pharma
Teva
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets